Nox 1/4 Inhibition to Treat Kidney Disease in Type 1 Diabetes
This study is testing whether a new tablet can help to treat kidney disease in people with T1D. This tablet blocks a key component of the pathway responsible for the oxidative stress that damages kidneys. Participants in this clinical trial will attend 10 study visits over 56 weeks.
This study has been approved by the South Metropolitan Health Service Human Research Ethics Committee.
For more information or to take part, contact firstname.lastname@example.org.